Is Cibus CFO’s $1.32 Share Sale a Signal of Strategic Change?
Insightful look at Cibus Inc.’s CFO insider sale: modest divestment, neutral market buzz, and key biotech earnings highlights—watch product milestones and regulatory moves to gauge future upside.
3 minutes to read
